Items where authors include "Wadsley, J."

Article

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Hapuarachi, B., Danson, S. orcid.org/0000-0002-3593-2890, Wadsley, J. orcid.org/0000-0002-1499-1277 et al. (1 more author) (2023) Exercise to transform tumours from cold to hot and improve immunotherapy responsiveness. Frontiers in Immunology, 14. 1335256. ISSN 1664-3224

Damm, M. orcid.org/0000-0001-7838-5762, Efremov, L., Jalal, M. et al. (8 more authors) (2023) Body composition parameters predict survival in pancreatic cancer—A retrospective multicenter analysis. United European Gastroenterology Journal. ISSN 2050-6406

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Brown, M., O’Connor, D., Turkington, R. et al. (8 more authors) (2023) Feasibility of delivering supervised exercise training following surgical resection and during adjuvant chemotherapy for pancreatic ductal adenocarcinoma (PRECISE): a case series. BMC Sports Science, Medicine and Rehabilitation, 15 (1). 116. ISSN 2052-1847

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736

Danson, S. orcid.org/0000-0002-3593-2890, Sirois, F. orcid.org/0000-0002-0927-277X, Fradley, K. orcid.org/0000-0002-2443-7368 et al. (8 more authors) (2023) Mental health burden for NHS healthcare staff during the COVID-19 pandemic: first results of a longitudinal survey. Heliyon, 9 (3). e13765. ISSN 2405-8440

Hillary, S.L., Chooi, J.E., Wadsley, J. orcid.org/0000-0002-1499-1277 et al. (3 more authors) (2022) Quality of life in post-surgical hypoparathyroidism (PoSH) in thyroid and parathyroid surgery. World Journal of Surgery, 46 (12). pp. 3025-3033. ISSN 1432-2323

Lee, R.W., Danson, S. orcid.org/0000-0002-3593-2890, Elliot, M. et al. (8 more authors) (2022) Importance of clinical research for the UK's 10-year cancer plan. The Lancet Oncology, 23 (8). pp. 975-978. ISSN 1470-2045

Ashley, L., Kassim, S., Kellar, I. et al. (8 more authors) (2022) Identifying ways to improve diabetes management during cancer treatments (INDICATE): protocol for a qualitative interview study with patients and clinicians. BMJ Open, 12 (2). e060402. ISSN 2044-6055

Taprogge, J., Wadsley, J. orcid.org/0000-0002-1499-1277, Miles, E. et al. (1 more author) (2021) Recommendations for multicentre clinical trials involving dosimetry for molecular radiotherapy. Clinical Oncology, 33 (2). pp. 131-136. ISSN 0936-6555

Corrie, P.G., Qian, W., Basu, B. et al. (31 more authors) (2020) Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma. British Journal of Cancer, 122 (12). pp. 1760-1768. ISSN 0007-0920

Craig, Z., Swain, J., Batman, E. et al. (16 more authors) (2020) NET-02 trial protocol: a multicentre, randomised, parallel group, open-label, phase II, single-stage selection trial of liposomal irinotecan (nal-IRI) and 5-fluorouracil (5-FU)/folinic acid or docetaxel as second-line therapy in patients with progressive poorly differentiated extrapulmonary neuroendocrine carcinoma (NEC). BMJ Open, 10 (2). e034527. ISSN 2044-6055

Brown, S.R., Hall, A., Buckley, H.L. et al. (9 more authors) (2019) Investigating the potential clinical benefit of Selumetinib in resensitising advanced iodine refractory differentiated thyroid cancer to radioiodine therapy (SEL-I-METRY): protocol for a multicentre UK single arm phase II trial. BMC Cancer, 19 (1). 582. ISSN 1471-2407

Tappenden, P. orcid.org/0000-0001-6612-2332, Carroll, C. orcid.org/0000-0002-6361-6182, Hamilton, J. orcid.org/0000-0003-3326-9842 et al. (5 more authors) (2019) Cabozantinib and vandetanib for unresectable locally advanced or metastatic medullary thyroid cancer: a systematic review and economic model. Health Technology Assessment, 23 (8). pp. 1-144. ISSN 1366-5278

Dehbi, H-M., Mallick, U., Wadsley, J. et al. (3 more authors) (2019) Recurrence after low-dose radioiodine ablation and recombinant human thyroid-stimulating hormone for differentiated thyroid cancer (HiLo): long-term results of an open-label, non-inferiority randomised controlled trial. Lancet Diabetes and Endocrinology, 7 (1). pp. 44-51. ISSN 2213-8587

Smyth, E.C., Cafferkey, C., Loehr, A. et al. (17 more authors) (2018) Genomic loss of heterozygosity and survival in the REAL3 trial. Oncotarget, 9 (94). pp. 36654-36665. ISSN 1949-2553

Wadsley, J., Gregory, R., Flux, G. et al. (6 more authors) (2017) SELIMETRY- a multicentre I-131 dosimetry trial: a clinical perspective. The British Journal of Radiology, 90 (1073). 20160637. ISSN 0007-1285

Neoptolemos, J.P., Palmer, D.H., Ghaneh, P. et al. (32 more authors) (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. Lancet, 389 (10073). pp. 1011-1024. ISSN 0140-6736

Akram, R., Wiltshire, J.J., Wadsley, J. et al. (1 more author) (2016) Adult Thyroglossal Duct Carcinoma of Thyroid Epithelial Origin: A Retrospective Observational Study. Indian Journal of Otolaryngology and Head and Neck Surgery. pp. 1-6. ISSN 0019-5421

Danson, S.J., Rowland, C., Rowe, R. et al. (7 more authors) (2015) The relationship between smoking and quality of life in advanced lung cancer patients: a prospective longitudinal study. Supportive Care in Cancer. ISSN 0941-4355

Edafe, O., Wadsley, J., Harrison, B.J. et al. (1 more author) (2014) Treatment related morbidity in differentiated thyroid cancer-a survey of clinicians. Thyroid Research, 7 (3). ISSN 1756-6614

Jones, A.M., Howarth, K.M., Martin, L. et al. (21 more authors) (2012) Thyroid cancer susceptibility polymorphisms: confirmation of loci on chromosomes 9q22 and 14q13, validation of a recessive 8q24 locus and failure to replicate a locus on 5q24. Journal of Medical Genetics, 49 (3). pp. 158-163. ISSN 0022-2593